Anti-angiogenesis Strategies In Cancer Therapies by SHAKER MOUSA

Anti-angiogenesis Strategies In Cancer Therapies

bySHAKER MOUSA, Paul Davis

Paperback | December 1, 2016

not yet rated|write a review

Pricing and Purchase Info

$130.46 online 
$143.95
Earn 652 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

Anti-angiogenesis Strategies in Cancer Therapeuticsprovides a detailed look at the current status and future directions in the discovery and development of novel anti-angiogenesis strategies in oncology. This book highlights the different mechanisms involved in the modulation of angiogenesis, including inflammation, thrombosis, and microRNA, and shows how nanotechnology can further enhance the potential of existing and new anti-angiogenesis approaches.

Written for industry scientists, researchers, oncologists, hematologists, and professors and students in the field, this comprehensive book covers all aspects of anti-angiogenesis strategies and their differences.



  • Covers important preclinical models and clinical trials in the discovery and development of novel anti-angiogenesis agents
  • Reviews FDA-approved anti-angiogenesis agents
  • Illustrates the value of nanotechnology in improving the utility of anti-angiogenesis agents
  • Offers insight into the development of novel anti-angiogenesis agents and future direction in this area

About The Author

Dr. Mousa came to Albany College of Pharmacy and Health Sciences in 2002 following a career of more than 17 years as a principal research scientist at DuPont Pharmaceuticals Co. Among Dr. Mousa's professional accomplishments are his contributions to many patents - he holds more than 250 U.S. and international patents - and to the disco...

Details & Specs

Title:Anti-angiogenesis Strategies In Cancer TherapiesFormat:PaperbackDimensions:210 pages, 8.75 × 6.35 × 0.68 inPublished:December 1, 2016Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:012802576X

ISBN - 13:9780128025765

Look for similar items by category:

Customer Reviews of Anti-angiogenesis Strategies In Cancer Therapies

Reviews

Extra Content

Table of Contents

1. Role of Angiogenesis and lymphogenesis in Cancer (tumor growth, Invasion, metastasis 2. Role of Angiogenesis and anti-angiogenesis in hematological malignancies (acute / chronic leukemia, lymphoma, myelodysplastic syndromes, myeloproliferative neoplasms) 3. The interface between Thrombosis-Inflammation and Angiogenesis 4. Micro RNA and Angiogenesis modulation 5. Preclinical discovery and development of different Pharmacological anti-angiogenesis agents 6. Differences among different anti-angiogenesis strategies (Mechanisms of actions) 7. Naturally Occurring Anti-angiogenesis 8. Clinical trials with anti-angiogenesis agents: Approved agents 9. Angiogenesis Biomarkers and Impact on personalized management 10. Efficacy of Anti-VEGF therapy in cancer 11. Nanotechnology in enhancing the utility of anti-angiogenesis agents Combinations with other anti-cancer agents 12. Multi-targeted anti-angiogenesis therapy in cancer 13. Combination of anti-angiogenesis and chemotherapeutics 14. Nanotechnology in enhancing the utility of anti-angiogenesis agents Combinations with other anti-cancer agents 15. Nano-targeted anti-angiogenesis agents in cancer detection 16. Future Directions